Edgen Stock·Sep 12 2025, 04:00返回
返回
Avidity Biosciences 推進 Del-Zota 加速 FDA 批准用於杜氏肌營養不良症
Edgen Stock·Sep 12 2025, 04:00
[1] Avidity Biosciences：《強力買入》基於Del-Zota (RNA) 加速審批申請 (https://seekingalpha.com/article/4822205-avid ...)[2] Avidity Biosciences: 基於Del-Zota加速審批申請維持「強力買入」評級 - Seeking Alpha (https://seekingalpha.com/article/4636000-avid ...)[3] KalVista Pharmaceuticals 提供營運更新並報告財季財務業績 (https://vertexaisearch.cloud.google.com/groun ...)